Clomipramine is NOT appropriate for treating PTSD
Clomipramine should not be used for PTSD treatment. The FDA has approved clomipramine exclusively for obsessive-compulsive disorder (OCD), not for PTSD 1. Current evidence-based guidelines consistently recommend SSRIs (sertraline, paroxetine, fluoxetine) or the SNRI venlafaxine as first-line pharmacotherapy for PTSD, with no support for clomipramine use in this condition 2.
Why Clomipramine Is Not Recommended for PTSD
Lack of Evidence and Approval
- FDA indication is limited to OCD only - the drug label explicitly states clomipramine is indicated solely for obsessions and compulsions in OCD patients 1
- No controlled trials support clomipramine efficacy in PTSD
- The 2024 VA/DoD PTSD Clinical Practice Guideline makes strong recommendations for specific SSRIs (paroxetine, sertraline) or venlafaxine, with no mention of clomipramine 2
Safety and Tolerability Concerns
Clomipramine carries significant risks that make it particularly unsuitable for PTSD:
- Higher adverse effect burden compared to SSRIs, including cardiovascular complications 3
- Risk of seizures, cardiac arrhythmias, and serotonin syndrome, especially when combined with other serotonergic agents 3
- Contraindicated after myocardial infarction and with MAOIs 1
- Common discontinuation due to side effects (20% dropout rate in trials) 1
- Requires careful dose adjustments based on CYP2D6 and CYP2C19 metabolizer status 4
Evidence-Based PTSD Pharmacotherapy Algorithm
First-Line Treatment
Start with an SSRI:
- Sertraline or paroxetine (FDA-approved for PTSD) 2, 5
- Alternative: fluoxetine 5, 6
- Trial duration: minimum 8-12 weeks at therapeutic doses 2, 7
- Continue for at least 12 months if effective 7
Second-Line Treatment (if SSRIs fail or not tolerated)
- Venlafaxine (SNRI) - has strong evidence 2, 5
- Other serotonin-potentiating agents: mirtazapine, nefazodone 5
Third-Line Treatment (treatment-resistant PTSD)
- Consider switching to a different SSRI/SNRI
- Augmentation with atypical antipsychotics (aripiprazole, risperidone) for psychotic symptoms or flashbacks 5, 8
- Prazosin specifically for nightmares and sleep disturbances 8
What NOT to Use
The VA/DoD guideline strongly recommends AGAINST:
Clinical Context: When Clomipramine Appears in PTSD Literature
The only relevant evidence involves:
Comorbid OCD + PTSD: One case report showed response to clomipramine combined with aripiprazole and psychotherapy in a patient with OCD, PTSD, AND dissociative identity disorder 9. This represents treatment of the OCD component, not PTSD specifically.
Treatment-resistant panic disorder with PTSD features: A 2026 systematic review noted clomipramine effectiveness in treatment-resistant panic disorder after CBT failure 10, but this addresses panic disorder, not PTSD.
Critical Pitfalls to Avoid
- Do not confuse OCD treatment evidence with PTSD treatment - clomipramine's proven efficacy in OCD does not translate to PTSD
- Do not use tricyclic antidepressants as first-line PTSD treatment - they have inferior safety profiles and inconsistent efficacy compared to SSRIs 5
- Do not prescribe clomipramine off-label for PTSD when evidence-based alternatives (SSRIs/SNRIs) are available and superior
Bottom Line
Use sertraline, paroxetine, or fluoxetine as first-line pharmacotherapy for PTSD. If these fail, try venlafaxine. Clomipramine has no role in PTSD treatment and carries unnecessary risks. The only scenario where clomipramine might be considered is when a patient has comorbid OCD requiring treatment, in which case you are treating the OCD, not the PTSD 1, 9.